Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0567 per EA under NDC 31722025305. Its NADAC has been published 112 times since May 8, 2024.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722025305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALLOPURINOLApproval Type
Generic (ANDA)
FDA Application
ANDA217748On Market Since
8/3/2023
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 112 times since May 8, 2024, and over the history we have for it it has declined 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0567 per EA |
|---|---|
| All-time high | $0.0715 (Oct 16, 2024) |
| All-time low | $0.0552 (Apr 22, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0552 |
| Median price | $0.0641 |
| Average price | $0.0638 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 112 |
| Tracking since | May 8, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0567 per EA (NDC 31722025305), effective Jun 24, 2026.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 10.6%. It has been tracked across 112 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since May 8, 2024, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0552 (Apr 22, 2026) to a high of $0.0715 (Oct 16, 2024), with a median of $0.0641 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ALLOPURINOL 300 MG TABLET, is $0.0563 per EA — about 1% below ALLOPURINOL 300 MG TABLET.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 31722025305) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification